• California signs into law transparency over drug pricing pharmafile
    October 11, 2017
    In a move that is guaranteed to result in further lawsuits and acrimony, California has signed into law a requirement for pharmaceutical companies to notify and explain any drug pricing increases above a certain threshold.
PharmaSources Customer Service